Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 100 participants.
Also called NCT01062516
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Ruttonjee Hospital
- Registry
-
NCT01062516
-
- Other papers using this trial's data
- Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01062516. Randomized; quadruple masking; primary purpose diagnostic. Start 2010-01 (registry gives no type); primary completion 2010-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin
- Condition
- Acute Coronary Syndrome
- Condition
- Acute Myocardial Infarction
- Intervention (Drug)
- esomeprazole 20 mg daily
- Intervention (Drug)
- famotidine 40 mg daily
- Lead sponsor
- Ruttonjee Hospital
Record details
- Record id
cardio:ct-nct01062516- Content hash
125b1d87858303dd7ad8954c97ccf874e3f53face54f77717158598e3492b3c7